The Danish dermatology company Leo Pharma has pumped money into a US based biotech company developing a medical device mainly to be used in treatments of a hair loss disease. It is also the first agreement made from Leo’s newly founded hub in Boston.
BY ELIZABETH MØNSTED JOHANSEN Offentliggjort 21.06.17 kl. 11:18
Log ind for at læse artikler
Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.
Sharing product-related news on the social media LinkedIn had consequences for an employee in the Danish unit of MSD. The post could be regarded as advertisement and has resulted in a fine from The Ethical Committee for the Pharmaceutical Industry.
The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.
The Swedish company Ascelia, managed by a former Sunstone director, has acquired the biotech company Oncoral and its cancer candidate, which is currently being tested in phase I trials at Herlev Hospital in Denmark.
The Danish-French biotech company Onxeo did not succeed with a phase III trial with drug candidate Livataq in patients with hepatocellular carcinoma (HCC). Now, the share price has dropped by nearly 50 percent and several banks have downgraded the price target of the Onxeo share.
Vi skal selvfølgelig have sunde forretninger, men medicinsalg handler ikke om tjene så mange penge som muligt. Det handler om at sikre, at borgerne får den rigtige behandling, skriver Anne Kahns, formand for Danmarks Apotekerforening, i denne klumme.